Wasserburger Arzneimittelwerk GmbH
Wasserburger Arzneimittelwerk GmbH, commonly referred to as Wasserburger, is a distinguished pharmaceutical company headquartered in Wasserburg am Inn, Germany. Founded in 1949, the company has established itself as a key player in the pharmaceutical industry, focusing on the development and production of high-quality medicinal products. Wasserburger's core offerings include a range of prescription medications and over-the-counter products, particularly in the fields of pain management and anti-inflammatory treatments. Their commitment to innovation and quality has earned them a strong market position, with a reputation for reliability and efficacy. With a robust operational presence across Europe, Wasserburger continues to achieve notable milestones, reinforcing its status as a trusted name in healthcare. The company’s dedication to research and development ensures that it remains at the forefront of the pharmaceutical sector, meeting the evolving needs of patients and healthcare professionals alike.
DitchCarbon Score
How does Wasserburger Arzneimittelwerk GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Financial Intermediation industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Wasserburger Arzneimittelwerk GmbH's score of 20 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Wasserburger Arzneimittelwerk GmbH's reported carbon emissions
Wasserburger Arzneimittelwerk GmbH, headquartered in Germany, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or climate commitments outlined by the company. In the absence of concrete emissions data, it is unclear how the company is addressing its carbon footprint or contributing to climate action within the pharmaceutical industry. As the sector increasingly focuses on sustainability, it is essential for companies like Wasserburger Arzneimittelwerk GmbH to establish clear climate commitments and reduction initiatives to align with global efforts in combating climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Wasserburger Arzneimittelwerk GmbH is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
